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prediabetes has been shown to be present in normoglycemic animals with periodontitis. As periodontal
bacterial species are significant sources of endotoxemia and may directly stimulate insulin secretion,
we hypothesized that increased bacterial virulence may exert an adverse effect on rat pancreatic ￿-cell
function via PI3K/AKT signaling. INS-1 cells and isolated pancreatic islets were cultured separately with
the following supernatants: Streptococcus anginosus, Streptococcus mutans, Fusobacterium nucleatum,
Prevotella intermedia, Porphyromonas gingivalis (P.g), and Treponema denticola (T.d). Supernatants
were purified from single bacterial cultures and prepared at different dilutions (100 pg/ml, 50 ng/ml, 200
ng/ml, and 500 ng/ml) to challenge INS-1 and islets. Gene expression (IL-1￿, TNF￿, IL-6, TLR2, TLR4,
Ins1, and Ins2) and insulin secretion were measured. The results showed upregulation of gene expression
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Abstract
Diabetes and periodontitis are considered associated chronic diseases, and hyperinsulinemia in prediabetes has been shown 
to be present in normoglycemic animals with periodontitis. As periodontal bacterial species are significant sources of endo-
toxemia and may directly stimulate insulin secretion, we hypothesized that increased bacterial virulence may exert an adverse 
effect on rat pancreatic β-cell function via PI3K/AKT signaling. INS-1 cells and isolated pancreatic islets were cultured 
separately with the following supernatants: Streptococcus anginosus, Streptococcus mutans, Fusobacterium nucleatum, 
Prevotella intermedia, Porphyromonas gingivalis (P.g), and Treponema denticola (T.d). Supernatants were purified from 
single bacterial cultures and prepared at different dilutions (100 pg/ml, 50 ng/ml, 200 ng/ml, and 500 ng/ml) to challenge 
INS-1 and islets. Gene expression (IL-1β, TNFα, IL-6, TLR2, TLR4, Ins1, and Ins2) and insulin secretion were measured. 
The results showed upregulation of gene expression up to 5.5-fold, not only as a result of the different dilutions used, but 
also due to bacterial virulence (p < 0.05). P.g and T.d supernatants demonstrated an increase in insulin secretion to fivefold 
at hypo- and hyperglycemia, yet stimulation from hypo- to hyperglycemia stays in the same ratio. Activation of TLR4/
PI3K/AKT signaling by supernatants in INS-1 cells resulted in increased IL-1β, TNFα, IL-6 gene expression levels, and 
AKT phosphorylation, which were abolished by TLR4 and PI3K/AKT signaling inhibitor. We demonstrated that bacterial 
supernatants derived from gram-negative species increasingly stimulate insulin secretion in β-cells and TLR4 may promote 
inflammation by activating the PI3K/AKT signaling pathway to induce pro-inflammatory molecules. Bacterial species, 
depending on their virulence, appear to play a role in the relationship between periodontitis and prediabetes by promoting 
insulin resistance and β-cell compensatory response.
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Introduction
Periodontitis is a chronic inflammatory disease featuring an 
immunological host response that leads to the destruction 
of periodontal tissues [1]. It is considered a multifactorial 
cause related to several environmental, genetic and acquired 
risk factors and intrinsically linked to the bacterial biofilm of 
specific endogenous oral species [2]. A continuous inflam-
matory reaction of gingival tissue will lead to alveolar bone 
loss and breakdown of surrounding connective tissues. Oral 
pathogenic bacteria can produce host tissue inflammation 
and bacterial endotoxins/lipopolysaccharides (LPS) from 
affected periodontal sites are likely to invade the circulatory 
system and induce endotoxemia [3, 4]. Consequently, this 
“periodontopathogenic leakage” of bacterial products could 
mediate inflammatory pathologies at distant organ sites. In 
fact, endotoxemia has been found to affect systemic health 
and is an increased risk factor for pneumonia, atherosclero-
sis, rheumatoid arthritis, adverse pregnancy outcome, and 
cancer [5–8]. Additionally, bacterial endotoxins may gener-
ate molecular responses, activating inflammation reactions 
 * Patrick R. Schmidlin 
 patrick.schmidlin@zzm.uzh.ch
1 Clinic of Preventive Dentistry, Periodontology 
and Cariology, Center of Dental Medicine, University 
of Zurich, Plattenstrasse 11, 8032 Zurich, Switzerland
2 Division of Endocrinology, Diabetes and Clinical Nutrition, 
University Hospital Zurich, Rämistrasse 100, 8091 Zurich, 
Switzerland
3 Department for Statistics, Ludwig-Maximilians-University 
Munich, Theresienstrasse 39/I, 80333 Munich, Germany
 Molecular and Cellular Biochemistry
1 3
in organs related to insulin storage and production, culmi-
nating in insulin resistance (IR) or diabetes mellitus [9, 10].
Although some studies suggest that periodontal dis-
ease could affect the development of diabetes [11, 12] and 
increase the risk of diabetic complications [13, 14], little 
mechanistic evidence has been published on the potential 
impact of periodontitis on diabetes. Animal studies to date 
have shown that hyperinsulinemia in β-cells occurs when 
insulin signaling downstream of the insulin receptor is 
impaired in insulin target organs and bacterial endotoxins 
can stimulate the production of cytokines and consequently 
IR in insulin target organs [9]. This signaling impairment is 
largely due to the existence of pro-inflammatory cytokines in 
the blood stream [15]. In fact, it was shown that IR appears 
in mice with induced periodontitis by applying LPS in the 
gingival sulcus [16]. Data regarding the impact of the major 
mediators of inflammation as bacterial endotoxins on β-cell 
function are still not clear, as some reports revealed stimulat-
ing [17] role of LPS in β-cell insulin secretion while others 
[18] report inhibiting role of LPS on insulin gene expression 
in isolated islets. In addition, the upstream signaling path-
ways that activate PI3K-AKT signaling to promote inflam-
mation response in pancreatic β-cell remain to be deter-
mined. Toll-Like Receptor 4 (TLR4) is a major component 
of the innate immune response and it is also present in non-
immune cells as pancreatic β-cells [19–21]. Circulating bac-
terial endotoxins binding TLR4 have been shown to activate 
inflammation via differentiation factor 88 (MyD88)-inde-
pendent pathways (i.e., MyD88-TRIF-PI3K/AKT pathway) 
and the evidence suggests that AKT1 activation in pancre-
atic islet cells increases β-cell mass and insulin production 
[22]. However, for the most part, the precise molecular and 
signaling mechanisms by which bacterial products affect 
β-cell insulin secretion are still left to explore.
As gram-negative bacterial products play an important 
role in the pathogenesis of periodontitis, we hypothesized 
that an increase in bacterial virulence may have a direct 
effect on INS-1 pancreatic β-cell line. To test our hypoth-
esis, we investigated the direct effect of different bacterial 
pathogenicities on rat immortalized β-cell line and isolated 
rat pancreatic islets by measuring insulin secretion and 
inflammation in vitro. We further evaluated whether TLR4-




A rat insulinoma (INS-1)-immortalized β-cell line was used 
to determine the effects of different bacterial supernatants 
on insulin production. INS-1 cells from the Division of 
Endocrinology, Diabetes and Clinical Nutrition, Univer-
sity Hospital Zurich, University of Zurich were maintained 
in Roswell Park Memorial Institute (RPMI) starvation or 
hypoglycemic medium supplemented with 10% fetal bovine 
serum, 100 U/ml penicillin, 100 U/ml streptomycin, 1 mM 
sodium pyruvate, 50 µl β-mercaptoethanol (Sigma-Aldrich, 
St. Louis, MO, USA) in an atmosphere of 5%  CO2 at 37 °C 
in a humidified incubator. Medium was changed every 
3–4 days and cells passaged once a week. The cells used in 
this study were between the 10th and 20th passage.
Rat pancreatic islet isolation and culture
Six male Wistar rats weighing 250 g (no defined age) were 
obtained from the Division of Endocrinology, Diabetes and 
Clinical Nutrition, University Hospital Zurich, University 
of Zurich. The animals were kept at 23 °C under a 12-h 
light–dark cycle, with free access to food and water. All 
experiments were conducted in accordance with the Swiss 
Animal Protection Laws and procedures were conducted 
with the relevant approval of the appropriate authorities. 
Islets were harvested from pancreata of male rats by col-
lagenase (collagenase NB8, Serva) digestion using the 
method of pancreas digestion, as previously described [23]. 
Islets were picked under a dissecting microscope, rinsed 
three times in Hanks solution, and cultured overnight in an 
incubator under 5%  CO2. The RPMI culture medium used 
contained 5.5 mM d-glucose (Invitrogen, Carlsbad, CA), 
10% FCS (fetal bovine serum) (HyClone Laboratories, Inc., 
Logan, UT), 100 U/ml penicillin, 100 U/ml streptomycin, 
and 40 µg/ml gentamicin (Invitrogen, Carlsbad, CA). Islets 
suspension was cultured in a 40-µm cell strainer (Falcon, 
Corning, NY, USA), and medium was isolated after glucose 
stimulation to determine insulin secretion.
Bacterial strains and cultured supernatants
Six bacterial species were used in this study: Streptococ-
cus mutans UAB159 (OMZ 918), Streptococcus angi-
nosus ATCC9895T (OMZ 871), Prevotella intermedia 
ATCC25611T (OMZ 278), Fusobacterium nucleatum KP-F8 
(OMZ 598), Porphyromonas gingivalis ATCC33277T 
(OMZ 308), and Treponema denticola ATCC35405T (OMZ 
661). T. denticola (T.d) was cultivated anaerobically in 10 ml 
of spirochetes medium (OMIZ-W68) at 37 °C. The other 
strains were cultured on Columbia Blood Agar (CBA) plates 
under the same anaerobic conditions. Liquid pre-cultures 
were prepared by inoculation of the bacterial colonies from 
the CBA plates into a modified fluid universal medium. The 
growth was obtained after 12–18 h of incubation in a shak-
ing incubator at 37 °C. All bacterial cultures were adjusted 
to  OD550 nm = 1.0 and centrifuged at 600×g for 10 min at 
4 °C. The supernatants were finally filter-sterilized (0.2 µm 
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filter) and made free from bacterial debris/cells and stored at 
− 80 °C. Then, supernatants were added to distinct working 
solutions in INS-1 cell culture media and made up to final 
dilution of 100 pg/ml, 50 ng/ml, 200 ng/ml, and 500 ng/
ml as applied in previous studies [24–26] for comparison 
among each bacterial species (i.e., 100 pg/ml means 1:1010 
dilution). Cell wall fragments, extracellular proteins, and 
secreted bacterial products typically compose the content 
of bacterial supernatant, but were not specifically identified 
or quantified for the series of experiments in this study. For 
the mixed supernatants, the dilution to their final concentra-
tions (100 pg/ml, 50 ng/ml, 200 ng/ml, and 500 ng/ml) was 
performed as follows: each of the six bacterial species was 
partially diluted in order to achieve the final dilution with all 
bacterial species mixed together (i.e., 16.67 pg/ml dilution 
for each of the six bacterial species, when all species mixed 
resulted in 100 pg/ml).
Glucose‑stimulation insulin secretion and insulin 
measurement in INS‑1 cells and isolated rat 
pancreatic islets
In order to validate their glucose response, INS-1 cells were 
first incubated in serum-free culture medium (supplements 
described above) containing 3.3 mM glucose at 37 °C. After 
24 h, the medium was replenished with RPMI, supplements 
and with 3.3 mM glucose. The bacterial supernatants of P. 
gingivalis (P.g) and T.d and mixed supernatants were added 
to working solutions/media and made up to a final dilution 
(0, 100 pg/ml, 50 ng/ml, 200 ng/ml, and 500 ng/ml) in single 
24-well plates specific for each bacterial strain overnight 
(16 h). Cells were washed and incubated with Krebs–Ringer 
bicarbonate HEPES buffer (KRBH, 135 mM NaCl, 3.6 mM 
KCl, 5 mM  NaHCO3, 0.5 mM  NaH2PO4, 0.5 mM  MgCl2, 
1.5 mM  CaCl2, and 10 mM HEPES, pH 7.4, and 0.1% 
bovine serum albumin) (Sigma, St. Louis, MO), 3.3 mM 
glucose (hypoglycemic glucose concentration) and super-
natants in different dilutions for 1 h at 37 °C. This minimal 
glucose solution was removed and replaced with KRBH plus 
16.7 mM glucose (hyperglycemic glucose concentration) 
with the same supernatant dilutions, and the cells were rein-
cubated for 1 h. For the insulin measurement in isolated rat 
pancreatic islets, 40 islets/well of 150–200 µm in diameter 
kept in 24-well plates were also pre-incubated with RPMI 
and supplements overnight with bacterial supernatants of 
P.g, T.d and mixed supernatants (0, 100 pg/ml, 50 ng/ml, 
200 ng/ml, and 500 ng/ml) in single 24-well plate specific 
for each bacterium. The pre-incubation medium was then 
replaced with KRBH buffer supplemented with different glu-
cose concentrations of 3.3 mM glucose and supernatants 
for 1 h and subsequently stimulated for 1 h with 16.7 mM 
glucose with supernatants. At the end of each stimulation for 
INS-1 and isolated islets, the medium was collected, cleared 
by centrifugation, and stored at − 80 °C for later analysis. 
Supernatants were assayed for insulin contents using Merco-
dia Ultra sensitive rat insulin ELISA kit (Crystal Chem, IL, 
USA). Secreted insulin levels were presented as % content.
Quantitative real‑time PCR (RT‑qPCR)
Gene expression analysis was conducted using only INS-1 
cell line which was seeded with hypoglycemic medium 
and then treated with isolated bacterial supernatants and 
mixed supernatants (0, 100 pg/ml, 50 ng/ml, 200 ng/ml, 
and 500 ng/ml) for 16 h. Briefly, total RNA was extracted 
from the cells with Trizol Reagent (Gibco, Life Technolo-
gies, Carlsbad, CA, USA) and quantified using NanoDrop 
ND-1000 (Thermo-Fisher Scientific, Wohlen, Switzerland). 
cDNA was synthesized using an iScript kit (Bio-Rad, Her-
cules, CA, USA). RT-qPCR reactions were carried out on a 
CFX96 real-time PCR system (Bio-Rad) by incubating ini-
tially for 2 min at 50 °C and 10 min at 95 °C, followed by 40 
cycles of 15 s at 95 °C and 1 min at 60 °C and run in a total 
reaction volume of 15µl, containing 7.5µl of SYBR®Green 
PCR Master Mix (Life Technologies, Zug, Switzerland), 6 µl 
of sample (1 ng), and 1.5 µl of primer solution of 1 µM (mix-
ture of forward and reverse primers). The authors selected 
specific genes related to two pathways for this study: (1) 
rat immune response: TLR2, TLR4, TNFα, IL-6, and IL-
1β and (2) rat insulin signaling: Ins1, Ins2. The following 
PCR primers were used in three independent experiments 
for further specific analysis: TLR2, 5′-GTA CGC AGT GAG 
TGG TGC AAGT-3′ and 5′-GGC CGC GTC ATT GTT CTC 
-3′, TLR4, 5′-AAT CCC TGC ATA GAG GTA CTT CCT AAT-
3′ and 5′-CTC AGA TCT AGG TTC TTG GTT GAA TAAG-3′, 
TNF-α, 5′-CCA GGA GAA AGT CAG CCT CCT-3′ and 5′-TCA 
TAC CAG GGC TTG AGC TCA-3′, IL-1β, 5′-CAC CTC TCA 
AGC AGA GCA CAG-3′ and 5′-GGG TTC CAT GGT GAA 
GTC AAC-3′, IL-6, 5′-CGA AAG TCA ACT CCA TCT GCC-3′ 
and 5′-GGC AAC TGG CTG GAA GTC TCT-3′, Ins1, 5′-TCT 
TCT ACA CAC CCA AGT CCCG-3′ and 5′-AGT GCC AAG 
GTC TGA AGA TCCC-3′, Ins2, 5′-ATC CTC TGG GAG CCC 
CGC -3′ and 5′-AGA GAG CTT CCA CCAAG-3′, GAPDH, 
5′-GCT CTC TGC TCC TCC CTG TT-3′ and 5′-CAC ACC GAC 
CTT CAC CAT CT-3′. From the Cq values obtained with the 
qPCR, the expression levels of transcripts were calculated by 
using the comparative Ct method ( 2−ΔΔCT formula) after nor-
malization to the internal reference gene (GAPDH). Results 
are presented in means ± standard deviations (SDs).
TLR4‑mediated PI3K/AKT signaling pathway 
inhibition
INS-1 cells were cultured (2 × 106 cells /well) to assess 
the production of cytokines after stimulation with mix-
ture of supernatants (500 ng/ml) and TLR4, PI3K, and 
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AKT inhibitors, each inhibitor in separate experiments for 
24 h. The blocking experiment was performed with TLR4 
inhibitor (500 nM viral inhibitory peptide, VIPER), PI3K 
inhibitor (500 nM NVP-BEZ235) and Pan AKT inhibitor 
(450 nM MK2206) (Imgenex, USA), in order to examine 
any change in the expression of cytokines IL-1β, IL-6, 
TNF-α (RT-qPCR) and AKT protein (western blot). After 
24 h of exposure, total RNA or total protein content was 
collected in triplicate, pooled, and frozen at − 80 °C until 
testing.
Western blot analysis
Western blotting was performed to determine the protein 
expression of AKT after inhibition of TLR4, PI3K, and 
AKT. Protein was extracted with radio-immunoprecipi-
tation assay (RIPA) buffer containing a protease inhibitor 
cocktail and centrifuged at 12,000× g for 15 min at 4 °C. 
The supernatant protein was quantified by bicinchoninic 
acid assay (BCA, Thermo Fisher Scientific, Rockford, 
USA) and stored at − 80 °C. Total lysates were resolved 
in SDS-PAGE. Proteins were blotted onto a nitrocellulose 
membrane and incubated with primary antibodies and the 
corresponding secondary antibodies. Immune complexes 
were visualized by the use of an enhanced chemilumi-
nescence western blotting system (Bio-Rad, Richmond, 
CA). Antibodies used for immunoblotting were as follows: 
mouse monoclonal antibody against pan AKT (40D4) and 
mouse monoclonal antibody against GAPDH (Cell Signal-
ing Technology, Beverly, MA, USA).
Statistical analysis
Statistical analysis was completed using IBM SPSS soft-
ware (IBM SPSS Statistics for Windows, version 23.0; 
IBM Corp., Armonk, NY). Linear mixed model statistics 
were performed to simultaneously explore the effect of the 
different bacterial supernatants, the different dilutions and 
the genes examined. The group differences were identified 
using post hoc tests with a Bonferroni correction for mul-
tiple comparisons. We assume that the repeated measure-
ments taken from the same bacterial supernatant with the 
same dilution are correlated. Simultaneous models usually 
increase the power of the statistical analysis compared to 
a large series of pairwise comparisons. In Figs. 1, 2, 3, 4, 
and 5, the data were presented together with the signifi-
cance of paired tests between the different configurations 
of genes, bacterial supernatants, and dilution. The quan-
titative data are presented as mean ±SD; p ≤ 0.05 was 
considered to be statistically significant.
Results
Different supernatant dilutions upregulated 
expression of immune response and insulin genes 
in INS‑1 β‑cells in hypoglycemic condition
The qPCR analysis showed an upregulation of IL-1β, IL-6, 
TNF-α, TLR2, and TLR4 genes in INS-1 β-cells after expo-
sure to different dilutions (100 pg/ml, 50 ng/ml, 200 ng/ml, 
and 500 ng/ml) of the bacterial supernatants, as compared 
to the INS-1 β-cell control treatment (Fig. 1). Upregula-
tion was found to be higher in β-cells when exposed to 
supernatants of P.g and T.d, both of which are well known 
and powerful periodontal pathogens. Thus, the increase of 
gene expression was dependent on the supernatant dilution 
and the increase in bacterial virulence: expression was 
up to 5.5-fold higher in the INS-1 cells exposed to higher 
concentrations of supernatants (i.e., 50–500 ng/ml) and 
for INS-1 cells in supernatants derived from pathogenic 
gram-negative bacteria. The statistical linear mixed-model 
analysis confirmed the explorative and pairwise-compar-
ison results.
The statistical model I included the IL-1β, IL-6, TNF-
α, TLR2, and TLR4 genes, the different dilutions, and the 
bacterial supernatants as fixed-effect factors. All main fac-
tors were significant (p < 0.05). Two interactions (Bacte-
ria * Dilution and Bacteria * Gene) were also significant 
(p < 0.05).
Supernatants also increased the expression of the two 
insulin-signaling pathway genes, Ins1 (a) and Ins2 (b), by 
2- to fivefold (p < 0.05) (see Fig. 2). The change in gene 
expression of Ins1 and Ins2 was found to be highest when 
cells were exposed to the bacterial supernatant of P.g and 
T.d.
The statistical model II included Ins1 and Ins2, different 
dilutions, and the bacterial supernatants as fixed-effect fac-
tors (p < 0.05). All main factors were significant (p < 0.05). 
One interaction (Bacteria * Dilution) was also significant 
(p < 0.05).
In a separate experiment, a mix of all bacterial superna-
tants at identical final dilutions was used to test the change 
in gene expression in INS-1 cells. The results showed an 
increase in gene expression (fivefold) for a dilution of 
100 pg/ml and were significant as compared to the expres-
sion in single bacterial species supernatant stimulation 
(Table 1), which provided no evidence of change.
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Treatment with supernatant dilutions of P.g and T.d 
elevated glucose‑stimulated insulin secretion 
in INS‑1 cells and isolated islets in both hypo‑ 
and hyperglycemic conditions
As P.g and T.d species caused higher gene expression, 
the measurement of the β-cell insulin secretion in INS-1 
and islets was only performed using these two bacte-
rial species. Figure 3 depicts the statistically significant 
(p < 0.05) increase in insulin production found after treat-
ment in INS-1 cells (a, b) and islets (c, d) in hypoglycemic 
(3.3 mM) and hyperglycemic (16.7 mM) conditions. In 
low glucose (3.3 mM) for INS-1 and islets, the applica-
tion of a 50 ng/ml supernatant increased the insulin secre-
tion up to threefold, while higher concentrations (200, 
500 ng/ml) induced a maximum of a ≈ fivefold increase in 
secretion. The insulin values for high (16.7 mM) glucose 
were approximately 4.2–5-fold compared to those of low 
(3.3 mM) glucose. Nevertheless, the stimulation index 
stays the same at 2.5-fold for both conditions, which is 
a normal stimulation index of insulin secretion in those 
conditions. A 100 pg/ml supernatant dilution did not lead 
to any significant change in insulin secretion for INS-1 and 
islets in low-glucose condition.
The statistical model III included the two bacterial 
supernatants (P.g and T.d) with different dilutions as fac-
tors for INS-1 cells and islets in the low-/high-glucose 
conditions. All factors and the Bacteria * Dilution interac-
tion were significant (p < 0.05).
Insulin secretion under the treatment with mixed 
supernatants was 5.5-fold higher in low (3.3 mM) glu-
cose conditions and 5× higher in high (16.7 mM) glucose 
conditions for both INS-1 cells (a) and islets (b) with the 
application of 50, 200, and 500 ng/ml of supernatants, 
whereas high (16.7 mM) glucose in the same supernatant 
dilutions induced a ≈ 2.5-fold increase.
Fig. 1  Bacterial supernatant treatments stimulated upregulation of 
immune response gene expressions in INS-1 β-cells. Quantitative 
PCR analysis shows increased expression of IL-1β (a), TNFα (b), IL-
6 (c), TLR2 (d), and TLR4 (e) under exposure to supernatants (S. ang-
inosus, S. mutans, F. nucleatum, P. intermedia, P. gingivalis, and T. 
denticola) compared to control (white bars). Upregulation was found 
to be higher when exposed to P. gingivalis and T. denticola and with 
50, 200, and 500 ng/ml of supernatants. x-axis: bacterial species and 
concentration of bacterial supernatants, y-axis: relative gene expres-
sions. Data are mean ± S.D. of at least three independent experiments; 
*p < 0.05
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Inhibition of TLR4/PI3K/AKT signaling 
down‑regulates INS‑1 cell cytokine production 
during bacterial mixed supernatant stimulation
To further examine the expression profiles of IL-1β, IL-6, 
TNF-α, RT-qPCR was adopted to detect inflammation 
after inhibition of TLR4/PI3K/AKT signaling and mixed 
supernatant treatment. VIPER was found to inhibit super-
natant-induced IL-1β, IL-6, TNF-α production compared 
with the control group (p < 0.05) (Fig. 5a). The results of 
western blotting confirmed decrease in AKT protein pro-
duction in the presence of supernatants and VIPER, which 
is in accordance with the results of RT-qPCR (Fig. 5a). 
Similar RT-qPCR results were found by inhibiting PI3K 
(Fig. 5b) and AKT signaling (Fig. 5c), where IL-1β, IL-6, 
TNF-α gene expression was also upregulated with super-
natant treatment whereas downregulated with the inhibitor 
and supernatant treatment. Taken together, the patterns of 
TLR4 expression were significantly associated with the 
presence of supernatant in the medium, suggesting that 
TLR4 activation may result in upregulation of PI3K/AKT 
signaling.
Discussion
The purpose of this study was to ascertain the importance 
of the bacterial virulence and its direct effect on pancreatic 
β-cell insulin secretion and inflammation response. Find-
ings suggest that bacterial supernatants, especially those 
derived from virulent gram-negative bacteria (P.g and T.d) 
in higher concentrations are able to augment insulin secre-
tion in β-cells either in hypo- or hyperglycemia. The latter 
result contradicts previous studies evaluating the effect of 
purified LPS on β-cells in hyperglycemia; in those studies, 
no significant change in insulin secretion was detected [17]. 
The selection of the supernatant dilution for our study was 
based on previous in vivo and in vitro assessments that have 
also investigated different concentrations of LPS (0–500 ng/
ml) [17, 24, 25]. These studies indicated that the elevation 
in LPS concentration may play a key role in low-grade sys-
temic inflammation, IR, and type-2 diabetes [26–28]. A 
number of cytokine genes are linked to diabetes with an 
inflammation-related etiology and induced immune response 
on β-cells [29]. Cytokines play an important role in the pro-
cedure of β-cell failure and IL-1β; TNF-α and IL-6 have 
been shown to diversely regulate pancreatic β-cell function 
leading to inflammation [29] in prediabetes patients [32, 33]. 
In fact, pro-inflammatory factors that are present at high 
levels in the blood of patients with type-2 diabetes are IL-1 
Fig. 2  Bacterial supernatant 
treatments stimulated upregula-
tion of insulin gene expressions 
in INS-1 β-cells. Increased 
expression of Ins1 (a) and Ins2 
(b) genes was found in 50, 
200, and 500 ng/ml compared 
to control (white bars). The 
supernatants of P. gingivalis and 
T. denticola showed a promi-
nent increase in gene expression 
compared to other bacterial 
species. x-axis: bacterial species 
and concentration of bacterial 
supernatants, y-axis: relative 
genes expression. *p < 0.05. 
Mean ± SD
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dependent, and blocking IL-1 activity has been shown to 
reduce their concentrations [30]. Similarly, elevated levels 
of circulating IL-6 can predict the incidence of type-2 dia-
betes in predisposed individuals [31]. Additionally, TLR2 
and TLR4 activation by LPS also triggers the secretion 
of other pro-inflammatory cytokines that contribute to IR 
[32]. In this study, the expression pattern of the genes IL-1β, 
IL-6, TNF-α, TLR2, TLR4, Ins1, and Ins2 showed upregula-
tion under exposure to 50, 200, and 500 ng/ml dilutions of 
supernatants from different bacteria. For this gene expres-
sion analysis, the INS-1 cells were not under any metabolic 
stress (low glucose level) and bacterial supernatants appear 
to have a direct influence on the INS-1 β-cells. Thus, the 
increase of gene expression was most likely dependent on 
the supernatant dilution and the increase in bacterial viru-
lence: expression was higher in the INS-1 cells exposed to 
higher concentrations of supernatants (i.e., 50–500 ng/ml) 
and of supernatants derived from pathogenic gram-negative 
bacteria (P.g and T.d; Figs. 1, 2). As the change in gene 
expression of Ins1 (Fig. 2a) and Ins2 (Fig. 2b) was found 
to be higher after exposure to the bacterial supernatant of 
P.g and T.d, the glucose-stimulated insulin secretion was 
conducted using only those two bacterial species for INS-1 
and isolated pancreatic islets. Treatment with supernatants 
elevated glucose-stimulated insulin secretion in INS-1 cells 
and isolated islets in both hypo- and hyperglycemic con-
ditions (Fig. 3). Concentration of 100 pg/ml supernatant 
concentration was too low to induce any change in insulin 
secretion in low-glucose condition (Fig. 4). Additionally, 
the treatment with mixed supernatants showed upregulation 
for all dilutions (Table 1), which was not observed with the 
use of single species alone (Fig. 1) and elevated glucose-
stimulated insulin secretion in INS-1 cells and isolated 
islets. According to current understanding, periodontitis 
Fig. 3  Effect of bacterial supernatant treatments of P. gingivalis and 
T. denticola on insulin secretion in INS-1 β-cells (a, b) and pancre-
atic islets (c, d) stimulated with 3.3  mM glucose (black bars) and 
16.7 mM glucose (white bars). The glucose-stimulated insulin secre-
tion was analyzed by ELISA and insulin secretion was presented as 
% content, showing similarly increased levels of secreted insulin in 
INS-1 β-cells and islets infected with P. gingivalis and T. denticola 
supernatants (50, 200, and 500 ng/ml) in stimulations with both 3.3 
and 16.7 mM glucose. x-axis: bacterial species and concentration of 
bacterial supernatants, y-axis: % content in insulin secretion in INS-1 
β-cells and islets. Data are mean ± SD of at least three independent 
experiments; *p < 0.05, **p < 0.01
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is mainly caused by a pathogenic subgingival biofilm [1, 
2] and not by single bacterial species. And the diversity in 
the species can shape development, function, structure, and 
virulence of the biofilm [33]. Throughout the progression of 
periodontitis, the biofilm releases several different bacterial 
by-products into the crevicular environment that, depending 
on the virulence of their content, may effectively stimulate 
inflammation [1, 4]. Those virulence factors may boost the 
bacterial capacity for infection. For instance, as opposed 
to LPS, the outer membrane vesicles stimulate maturation 
and release of cytokines by macrophages and dendritic cells 
and may promote the pathogenesis of infections [34–36]. 
Each of the gram-negative species used in the supernatant 
mixture possesses a large number of virulence factors rel-
evant to inducing inflammation. The authors believe that 
the mixture of these virulence factors could have a synergy 
and consequently aggravate the pancreatic cell response. In 
comparison with the literature, polymicrobial synergy due 
to combined virulence factors can occur when infections are 
caused by more than one species and they are more severe 
than the sum of the individual species acting alone [37].
Moreover, we uniquely reported the requirement for 
TLR4 and PI3K/AKT signaling in bacterial supernatant 
accretion of β-cell inflammation gene expression. This 
increase was observed in previous studies that demon-
strated the influence of purified LPS on pancreatic cells 
[26, 32] and identified that LPS may cause an increase 
in insulin production at normoglycemic levels [17]. 
Secretion of IL-1β, IL-6, TNF-α was highly inducible by 
supernatant treatment alone, whereas ATK/PI3K inhibi-
tion decreased IL-1β, IL-6, TNF-α release after superna-
tant treatment (Fig. 5). A direct effect of the supernatant 
challenge on TLR4 signaling appeared to significantly 
contribute to the supernatant-induced β-cell inflamma-
tion through the ATK/PI3K signaling. Accordingly, it was 
also reported that TLR4 activation by endotoxins resulted 
in enhanced AKT phosphorylation while silencing TLR4 
with siRNA resulted in the opposite effect, indicating 
activation through PI3K/AKT signaling pathway [38]. It 
can be speculated that other bacterial by-products in the 
supernatants, not just LPS, influenced our results and led 
to increased insulin secretion under high-glucose condi-
tion for INS-1 cells and isolated pancreatic islets. How-
ever, it is unclear if increased insulin secretion occurred 
in response to impaired insulin signaling on insulin tar-
get organs in vivo, resulting in β-cell compensation, or if 
other factors stimulated insulin secretion. Insights into the 
mechanism of hyperinsulinemia may be key to understand-
ing how periodontal bacteria influence the development of 
diabetes and underline the need for further investigation.
This study has taken a step in the direction of defining 
the direct impact of the type of periodontal microbiota on 
insulin regulation by activating the TLR4-mediated PI3K/
AKT signaling pathway to promote inflammation. Our data 
demonstrated to some extend that gram-negative bacterial 
supernatants induce cytokine expression and increase insu-
lin production. To our knowledge, we are the first to report 
the effect of whole bacterial supernatants on pancreatic 
cells. This study certainly cannot be regarded as conclu-
sive since it has not been shown whether bacterial products 
could directly reach pancreatic cells in a living organ even 
though clinical studies reported short-time bacteremia in 
the peripheral blood of periodontal patients [3, 4]. Since 
sufficient evidence has not been reported, the proof such as 
Fig. 4  Effect of mixed bacterial supernatants on insulin secretion in 
INS-1 β-cells (a) and pancreatic islets (b) stimulated with 3.3  mM 
glucose (black bars) and 16.7 mM glucose (white bars). The glucose-
stimulated insulin secretion (ELISA) upon mixed supernatant treat-
ment showed higher increases for INS-1 and pancreatic islets in 50, 
200, and 500 ng/ml compared with the control. Data are mean ± SD 
of at least three independent experiments;*p < 0.05, **p < 0.01
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isolation of bacterial products from the pancreas of diabetic 
animals using an experimental periodontitis model with bac-
teria would ideally still be needed. In addition, there is no 
strong evidence for direct impact of the type of periodontal 
microbiota on diabetic or glycemic regulation.
In conclusion, we have demonstrated that supernatants 
of different bacteria in various dilution rates induce pro-
inflammatory cytokines and increase insulin secretion in the 
pancreatic β-cell line INS-1 and isolated pancreatic islets 
in low and high glucose through the TLR4-mediated PI3K/
Fig. 5  Mixed bacterial super-
natants trigger TLR4-mediated 
PI3K/AKT signaling in INS-1. 
For analysis of mRNA expres-
sion of IL-1β, TNFα, IL-6, 
INS-1 cells were cultivated 
in the presence or absence of 
mixed supernatants (500 ng/
ml), with or w/o TLR4/VIPER 
(a), PI3K inhibitor (b) and Pan 
AKT inhibitor (c) for 24 h. 
Western blot was performed to 
detect activation state of AKT 
and its concentration activation 
was determined (a, b). Relative 
mRNA expression was deter-
mined by RT-PCR. Molecular 
weights of bands are expressed 
in kDa. Representative immu-
noblots are shown. Graphs are 
presented as means ± SEM from 
at least three independent exper-
iments. Statistically significant 
difference in comparison to 
control, INS-1 in the absence of 
supernatants (set as 1): by t-test: 
*p < 0.05
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AKT signaling. The findings come in direct support to sus-
tain oral bacterial supernatants as significant contributors 
for the development of β-cell inflammation and compensa-
tion, which may contribute to prediabetes in individuals with 
periodontitis.
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